EUROPEAN SOCIETY FOR VASCULAR SURGERY
Activities to relieve sickness and to preserve and protect health by advancing for the public benefit the science and art and research into Vascular disease including (without limitation) vascular surgery.
Objects
TO RELIEVE SICKNESS AND TO PRESERVE AND PROTECT HEALTH BY ADVANCING FOR THE PUBLIC BENEFIT THE SCIENCE AND ART AND RESEARCH INTO VASCULAR DISEASE INCLUDING (WITHOUT LIMITATION) VASCULAR SURGERY.
Financial health, per its FY2024 accounts
The charity reported a surplus of €385,000 for the year ended 31 December 2024, with total income of €3,066,456 and total expenditure of €2,681,456. Free reserves stood at €2,027,019, which is below the trustees' stated target range of €2,200,000 to €2,600,000. The accounts were prepared on a going concern basis with no material uncertainties identified by the auditors.
What the accounts disclose
“One employee (2023: one) within the group (not within the charity) received remuneration of more than €70,000.” — page 23
“One employee (2023: one) within the group (not within the charity) received remuneration of more than €70,000.” — page 23
“During the year the Trustees reviewed the level of free reserves that the Society should hold and concluded that an appropriate level would be between €2,200,000 and €2,600,000” — page 6
“During the year the charity received income under gift aid of the trading profits from European Vascular Surgery Journals Limited amounting to €273,177” — page 26
“During the year European Vascular Surgery Trading Limited was invoiced €569,025 (2023: €568,732) and the charity was invoiced €56,759 (plus irrecoverable VAT) (2023: €40,000) by SASU ESVS France in respect of administration services and associated recharges.”
“During the year the charity received income under gift aid of the trading profits from European Vascular Surgery Journals Limited amounting to €273,177” — page 26
“During the year European Vascular Surgery Trading Limited was invoiced €569,025 (2023: €568,732) and the charity was invoiced €56,759 (plus irrecoverable VAT) (2023: €40,000) by SASU ESVS France in respect of administration services and associated recharges.”
“The charity has two active subsidiaries. European Vascular Surgery Trading Limited (EVSTL) manages a number of the Society's activities and in turn owns SASU ESVS France, which operates the Society’s administrative office.” — page 8
Policies the charity declares
- Financial reserves policy and procedures
- Internal charity financial controls policy and procedures
- Internal risk management policy and procedures
- Investing charity funds policy and procedures
- Risk management
- Trustee conflicts of interest policy and procedures
- Trustee expenses policy and procedures
From the charity’s annual return (Part A, self-declared)
Self-declared on the annual return for the financial year ending 31/12/2025
- Volunteers: 147
- Trustee benefits, answered Yes to: any trustee benefit; payments to trustees for acting as trustee
- Has a trading subsidiary
Self-declared on the annual return for the financial year ending 31/12/2024
- Trustee benefits, answered Yes to: any trustee benefit; payments to trustees for acting as trustee
- Has a trading subsidiary
Self-declared on the annual return for the financial year ending 31/12/2023
- Volunteers: 120
- Trustee benefits, answered Yes to: any trustee benefit; payments to trustees for acting as trustee; other trustee benefit
- Has a trading subsidiary
Leadership, per the charity’s website
- Armando Mansilha — President
- Robert Hinchliffe — Secretary General
- Kak Khee Yeung — President Elect
- Pirkka Vikatmaa — Deputy President Elect
- Vincent Jongkind — Treasurer
- Jonathan Boyle — EJVES Editor-in-Chief
- Nadia Hakkenbrak — EVST Secretary
- Zoran Rancic — ESVS Academy Chair
Structured financials (annual return, FY ending 31/12/2025)
Trustees
- Arindam Chaudhuri
- Dr Igor Koncar
- Jonathan Boyle
- Kak Khee Yeung
- Nadia Hakkenbrak
- Pirkka Vikatmaa
- Professor Robert Hinchliffe
- Vincent Jongkind
- Zoran Rancic
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/12/2025 | £3.4m | £3.0m |
| 31/12/2024 | £2.5m | £2.2m |
| 31/12/2023 | £2.2m | £2.2m |
| 31/12/2022 | £2.4m | £2.3m |
| 31/12/2021 | £1.3m | £1.1m |
Common questions
Is EUROPEAN SOCIETY FOR VASCULAR SURGERY financially healthy?
Per its FY2024 accounts: The charity reported a surplus of €385,000 for the year ended 31 December 2024, with total income of €3,066,456 and total expenditure of €2,681,456. Free reserves stood at €2,027,019, which is below the trustees' stated target range of €2,200,000 to €2,600,000. The accounts were prepared on a going concern basis with no material uncertainties identified by the auditors. Its FY2024 accounts were audited by Azets Audit Services Limited.
What does the highest-paid employee of EUROPEAN SOCIETY FOR VASCULAR SURGERY earn?
Per its FY2024 accounts, the highest-paid employee was in the more than €70,000 band, and 1 employees earned over £60,000.
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| BRITISH HEART FOUNDATION | 1 | £1.7m |
| HEART RESEARCH UK | 1 | £60k |
Charities like this
- THE EUROPEAN ASSOCIATION FOR CARDIO-THORACIC SURGERY
- THE VASCULAR SOCIETY
- EUROPEAN SOCIETY OF THORACIC SURGEONS
- BRITISH SOCIETY OF ENDOVASCULAR THERAPY
- EUROPEAN SOCIETY OF CATARACT AND REFRACTIVE SURGEONS LIMITED
- EUROPEAN SOCIETY FOR CLINICAL VIROLOGY
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| EUROPEAN SOCIETY FOR VASCULAR SURGERY | £3.4m | more than €70,000 | 1 | unclear | — | no doubt |
| THE EUROPEAN ASSOCIATION FOR CARDIO-THORACIC SURGERY | £6.1m | — | — | unclear | — | no doubt |
| THE VASCULAR SOCIETY | £590k | — | 0 | unclear | — | no doubt |
| EUROPEAN SOCIETY OF THORACIC SURGEONS | £1.8m | €100,001 - €110,000 | 2 | above | — | no doubt |
| BRITISH SOCIETY OF ENDOVASCULAR THERAPY | £364k | — | 0 | above | — | no doubt |
| EUROPEAN SOCIETY OF CATARACT AND REFRACTIVE SURGEONS LIMITED | £18.5m | €230,001 - €240,000 | 2 | above | — | no doubt |